STOCK TITAN

Addus HomeCare Announces Third Quarter 2024 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Addus HomeCare reported strong Q3 2024 financial results with net service revenues increasing 7.0% to $289.8 million. Net income reached $20.2 million ($1.10 per diluted share), while adjusted EBITDA grew 11.1% to $34.3 million. The company's personal care segment, representing 74.3% of revenues, achieved 6.8% organic growth. Cash flow from operations was $48.5 million, and the company maintained strong liquidity with $222.9 million in cash. Addus announced plans to acquire Gentiva's personal care operations, expanding their service area to seven new states.

Addus HomeCare ha riportato risultati finanziari solidi per il terzo trimestre del 2024, con ricavi netti da servizi che sono aumentati del 7,0%, raggiungendo i 289,8 milioni di dollari. L'utile netto ha toccato i 20,2 milioni di dollari (1,10 dollari per azione diluita), mentre l'EBITDA rettificato è cresciuto dell'11,1%, raggiungendo i 34,3 milioni di dollari. Il segmento di cura personale dell'azienda, che rappresenta il 74,3% dei ricavi, ha registrato una crescita organica del 6,8%. Il flusso di cassa dalle operazioni è stato di 48,5 milioni di dollari e l'azienda ha mantenuto una forte liquidità con 222,9 milioni di dollari in contante. Addus ha annunciato piani per acquisire le operazioni di cura personale di Gentiva, espandendo la propria area di servizio a sette nuovi stati.

Addus HomeCare reportó sólidos resultados financieros en el tercer trimestre de 2024, con ingresos netos por servicios que aumentaron un 7,0% hasta alcanzar los 289,8 millones de dólares. La renta neta alcanzó los 20,2 millones de dólares (1,10 dólares por acción diluida), mientras que el EBITDA ajustado creció un 11,1% hasta 34,3 millones de dólares. El segmento de cuidado personal de la empresa, que representa el 74,3% de los ingresos, logró un crecimiento orgánico del 6,8%. El flujo de caja de las operaciones fue de 48,5 millones de dólares, y la compañía mantuvo una sólida liquidez con 222,9 millones de dólares en efectivo. Addus anunció planes para adquirir las operaciones de cuidado personal de Gentiva, ampliando su área de servicio a siete nuevos estados.

Addus HomeCare는 2024년 3분기 재무 결과가 우수하다고 보고했으며, 서비스 수익이 7.0% 증가하여 2억 8980만 달러에 도달했습니다. 순이익은 2020만 달러(희석 주당 1.10달러)에 이르렀으며, 조정 EBITDA는 11.1% 성장하여 3430만 달러에 달했습니다. 회사의 개인 돌봄 부문은 수익의 74.3%를 차지하며, 6.8%의 유기적 성장을 달성했습니다. 운영에서의 현금 흐름은 4850만 달러였으며, 회사는 2억 2290만 달러의 현금을 보유하여 강력한 유동성을 유지했습니다. Addus는 Gentiva의 개인 돌봄 운영을 인수할 계획을 발표하여 서비스 공간을 7개의 새로운 주로 확대했습니다.

Addus HomeCare a annoncé des résultats financiers solides pour le troisième trimestre 2024, avec des revenus nets de services en hausse de 7,0 %, atteignant 289,8 millions de dollars. Le revenu net a atteint 20,2 millions de dollars (1,10 dollar par action diluée), tandis que l'EBITDA ajusté a augmenté de 11,1 %, pour un total de 34,3 millions de dollars. Le segment de soins personnels de l'entreprise, représentant 74,3 % des revenus, a enregistré une croissance organique de 6,8 %. Le flux de trésorerie provenant des opérations s'élevait à 48,5 millions de dollars, et l'entreprise a maintenu une solide liquidité avec 222,9 millions de dollars en espèces. Addus a annoncé des plans pour acquérir les opérations de soins personnels de Gentiva, élargissant ainsi son espace de service à sept nouveaux États.

Addus HomeCare berichtete über starke finanzielle Ergebnisse im 3. Quartal 2024, mit einem Anstieg der Netto-Service-Einnahmen um 7,0 % auf 289,8 Millionen Dollar. Der Nettogewinn erreichte 20,2 Millionen Dollar (1,10 Dollar pro verwässerter Aktie), während das adjustierte EBITDA um 11,1 % auf 34,3 Millionen Dollar anwuchs. Der persönliche Pflegesektor des Unternehmens, der 74,3 % der Einnahmen ausmacht, verzeichnete ein organisches Wachstum von 6,8 %. Der Cashflow aus der Betriebstätigkeit betrug 48,5 Millionen Dollar, und das Unternehmen wies eine starke Liquidität von 222,9 Millionen Dollar in Barvermögen auf. Addus kündigte Pläne an, die persönlichen Pflegeoperationen von Gentiva zu übernehmen und somit ihr Servicegebiet auf sieben neue Bundesstaaten auszudehnen.

Positive
  • Net service revenues increased 7.0% YoY to $289.8 million
  • Net income grew 31.2% YoY to $20.2 million
  • Adjusted EBITDA increased 11.1% to $34.3 million
  • Personal care segment achieved 6.8% organic growth
  • Strong cash position of $222.9 million
  • Hospice revenues up 3.5% on same-store basis
Negative
  • Share dilution due to public offering of 1,725,000 shares in June 2024

Insights

The Q3 2024 results demonstrate robust financial performance with $289.8M in revenue, up 7.0% year-over-year and adjusted EBITDA growth of 11.1% to $34.3M. Key highlights include strong organic growth in personal care services at 6.8% and improved profitability with adjusted net income per share increasing 13.0% to $1.30.

The company's balance sheet remains solid with $222.9M in cash and over $500M in credit facility availability. The pending Gentiva acquisition and expansion into Texas position ADUS for significant market share growth. The increased credit facility to $650M provides additional financial flexibility for future growth initiatives.

The strategic focus on personal care services, comprising 74.3% of revenue, aligns well with industry trends toward home-based care solutions. The acquisition of Tennessee Quality Care and planned Gentiva integration demonstrate smart vertical integration in key markets. The expansion making ADUS the largest provider in Texas represents a significant competitive advantage for workforce retention and value-based contracting.

The steady improvement in hospice business with 3.5% same-store growth indicates successful execution in clinical services diversification. The company's expanding scale across the care continuum positions it favorably amid increasing demand for home-based healthcare alternatives.

FRISCO, Texas--(BUSINESS WIRE)-- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2024.

Third Quarter 2024 Highlights:

  • Net Service Revenues Increase 7.0% to $289.8 Million
  • Net Income of $20.2 Million, or $1.10 per Diluted Share
  • Adjusted Net Income per Diluted Share Increases 13.0% to $1.30
  • Adjusted EBITDA Increases 11.1% to $34.3 Million
  • Cash Flow from Operations of $48.5 Million

Overview

Net service revenues were $289.8 million for the third quarter of 2024, a 7.0% increase compared with $270.7 million for the third quarter of 2023. Net income was $20.2 million for the third quarter of 2024, compared with $15.4 million for the third quarter of 2023, while net income per diluted share was $1.10 compared with $0.95 for the same period a year ago. Adjusted EBITDA increased 11.1% to $34.3 million for the third quarter of 2024 from $30.9 million for the third quarter of 2023. Adjusted net income was $23.8 million for the third quarter of 2024 compared with $18.8 million for the prior-year period, while adjusted net income per diluted share was $1.30 compared with $1.15 for the third quarter of 2023. Adjusted net income per diluted share for the third quarter of 2024 excludes acquisition expenses of $0.08 and stock-based compensation expense of $0.12. The weighted average number of shares outstanding increased to approximately 18.3 million from approximately 16.5 million in the second quarter primarily as a result of the completed public offering of 1,725,000 shares on June 28, 2024 (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

For the first nine months of 2024, net service revenues increased 9.6% to $857.5 million from $782.3 million for the prior-year period. Net income was $54.1 million for the first nine months of 2024 compared with $42.9 million for the same period in 2023, and net income per diluted share was $3.17 compared with $2.63 per diluted share. Adjusted EBITDA increased 19.4% to $102.0 million for the first nine months of 2024 from $85.4 million for the first nine months of 2023. Adjusted net income was $65.9 million for the first nine months of 2024 compared with $52.1 million for the first nine months of 2023, while adjusted net income per diluted share was $3.86 compared with $3.20 for the prior-year period.

Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Addus delivered another strong financial and operating performance for the third quarter of 2024, highlighted by 7.0% top line growth and 11.1% growth in Adjusted EBITDA compared to the third quarter of 2023. These results reflect the consistent favorable growth trends we have delivered to date in 2024, driven by solid organic growth and the contribution from recent acquisitions. Demand for our services continues to fuel our growth, reflecting a greater awareness of the value of home-based care as the preferred and most cost-effective option for many individuals. With our expanding scale and market coverage, Addus is well positioned to meet this demand with our ability to offer home-based services across the care continuum.

“Our personal care business continued to perform well, accounting for 74.3% of our overall revenues for the third quarter of 2024, with higher patient volumes supported by favorable hiring trends. Personal care has been the key growth driver for Addus this year with consistent year-over-year improvement. For the third quarter of 2024, we delivered 6.8% organic growth in revenue on a same-store basis over the corresponding period last year, reflecting robust demand and favorable reimbursement support across the markets where we operate.

“On the clinical side, our results included the operations of Tennessee Quality Care, a provider of home health, hospice, and private duty nursing services, acquired by Addus on August 1, 2023. We continued to see steady improvement in our hospice business with revenues up 3.5% on a same-store basis and a modest increase in average daily census compared with the third quarter last year. Our home health business, which is our smallest segment, accounted for 5.9% of total revenue for the third quarter of 2024,” said Allison.

Cash and Liquidity

As of September 30, 2024, the Company had cash of $222.9 million with capacity and availability under its revolving credit facility of $511.5 million and $503.5 million, respectively. Net cash provided by operating activities was $48.5 million for the third quarter of 2024, inclusive of a one-time working capital benefit of $9.7 million expected to revert in the fourth quarter. As previously disclosed, subsequent to the end of the quarter, Addus entered into an Amended and Restated Credit Agreement to increase the Company’s revolving credit facility from $600 million to $650 million and extend the maturity date through July 2028.

Looking Ahead

Allison added, “We will continue to maintain a conservative balance sheet and pursue a capital allocation strategy that brings additional value to our shareholders. Acquisitions represent a significant use of capital for Addus, and we will continue to target operations that are aligned with our overall growth strategy to add clinical services where we have a strong personal care presence. We will also seek opportunities to add operations in select personal care markets where we can enter at scale. In line with this strategy, during the second quarter, we announced a definitive agreement to acquire the personal care operations of Gentiva. These operations deliver personal care services to over 16,000 patients per day in a seven-state service area, including Texas and Missouri, which are new states for Addus. We are excited about the opportunity to expand our market reach, especially in Texas where we will become the largest provider of personal care services. Having broader market coverage supports our ability to hire and retain caregivers and also provides Addus with an advantage in developing value-based contract arrangements. We expect to close the Gentiva acquisition in the fourth quarter of 2024, and our team has been diligently working on transition planning to integrate these operations.

“As we continue to expand our operations, we are proud of the leadership role we are playing in meeting the critical need for home-based care. We commend the work of our dedicated caregivers across our operations who make this possible for more patients and their families. We are excited about the opportunities ahead to build on our momentum, and we look forward to another successful year for Addus in 2024,” added Allison.

Non-GAAP Financial Measures

The information provided in this release includes adjusted net income, adjusted EBITDA, and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before gain or loss on sale of assets, impact of retroactive New York rate increases, acquisition expenses, stock-based compensation expenses, and restructure and other non-recurring costs. The Company defines adjusted EBITDA as earnings before interest expense, gain or loss on sale of assets, taxes, depreciation, amortization, impact of retroactive New York rate increases, acquisition expense, stock-based compensation expense, and restructure and other non-recurring costs. The Company defines adjusted net income per diluted share as net income per share, adjusted for the impact of retroactive New York rate increases, acquisition expenses, stock-based compensation expense, and restructure and other non-recurring costs. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted net income per share to net income per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted net income per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers.

Conference Call

Addus will host a conference call on Tuesday, November 5, 2024, at 9:00 a.m. Eastern time. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on November 12, 2024, by dialing (877) 344-7529 (international dial-in number is (412) 317-0088) and entering pass code 4366280.

A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.

Forward-Looking Statements

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 27, 2024, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to over 48,500 consumers through 214 locations across 22 states. For more information, please visit www.addus.com.

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(amounts and shares in thousands, except per share data)

(Unaudited)

 
Income Statement Information:

For the Three Months
Ended September 30,

 

For the Nine Months
Ended September 30,

2024

 

2023

 

2024

 

2023

 
Net service revenues

$

289,787

 

$

270,721

 

$

857,455

 

$

782,300

 

Cost of service revenues

 

197,583

 

 

183,991

 

 

583,916

 

 

534,837

 

 
Gross profit

 

92,204

 

 

86,730

 

 

273,539

 

 

247,463

 

 

31.8

%

 

32.0

%

 

31.9

%

 

31.6

%

General and administrative expenses

 

62,805

 

 

60,271

 

 

187,444

 

 

174,028

 

Depreciation and amortization

 

3,446

 

 

3,620

 

 

10,316

 

 

10,449

 

Total operating expenses

 

66,251

 

 

63,891

 

 

197,760

 

 

184,477

 

 
Operating income

 

25,953

 

 

22,839

 

 

75,779

 

 

62,986

 

 
Total interest expense, net

 

(1,335

)

 

2,619

 

 

2,640

 

 

7,014

 

 
Income before income taxes

 

27,288

 

 

20,220

 

 

73,139

 

 

55,972

 

Income tax expense

 

7,125

 

 

4,809

 

 

19,067

 

 

13,034

 

 
Net income

$

20,163

 

$

15,411

 

$

54,072

 

$

42,938

 

 
Net income per diluted share:

$

1.10

 

$

0.95

 

$

3.17

 

$

2.63

 

 
Weighted average number of common shares outstanding:

Diluted

 

18,255

 

 

16,286

 

 

17,065

 

 

16,307

 

 
 
Cash Flow Information:

For the Three Months
Ended September 30,

 

For the Nine Months
Ended September 30,

2024

 

2023

 

2024

 

2023

 
Net cash provided by operating activities

$

48,525

 

$

21,785

 

$

106,016

 

$

82,198

 

Net cash (used in) investing activities

 

(1,922

)

 

(111,223

)

 

(124

)

 

(113,934

)

Net cash provided by financing activities

 

2,944

 

 

85,000

 

 

52,169

 

 

31,525

 

 
Net change in cash

 

49,547

 

 

(4,438

)

 

158,061

 

 

(211

)

Cash at the beginning of the period

 

173,305

 

 

84,188

 

 

64,791

 

 

79,961

 

Cash at the end of the period

$

222,852

 

$

79,750

 

$

222,852

 

$

79,750

 

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(Amounts in thousands)

(Unaudited)

 

 

 

 

 

September 30,

 

2024

 

2023

 
Assets
 
Current assets
Cash

$

222,852

$

79,750

Accounts receivable, net

 

96,600

 

121,112

Prepaid expenses and other current assets

 

13,362

 

10,387

 
Total current assets

 

332,814

 

211,249

 
Property and equipment, net

 

23,716

 

20,516

 
Other assets
Goodwill

 

663,614

 

662,981

Intangible assets, net

 

86,606

 

93,799

Operating lease assets

 

44,535

 

47,183

Other long-term assets

 

1,616

 

-

Total other assets

 

796,371

 

803,963

 
Total assets

$

1,152,901

$

1,035,728

 
Liabilities and stockholders' equity
 
Current liabilities
Accounts payable

$

27,726

$

21,375

Accrued payroll

 

57,982

 

51,774

Accrued expenses

 

34,257

 

34,952

Operating lease liabilities - current portion

 

11,155

 

11,434

Government stimulus advance

 

13,655

 

7,836

Accrued workers compensation

 

13,043

 

12,268

Total current liabilities

 

157,818

 

139,639

 
Long-term debt, less current portion, net of debt issuance costs

 

-

 

163,917

Long-term lease liability, less current portion

 

38,608

 

41,632

Other long-term liabilities

 

8,841

 

6,206

Total long-term liabilities

 

47,449

 

211,755

 
Total liabilities

 

205,267

 

351,394

 
Total stockholders' equity

 

947,634

 

684,334

 
Total liabilities and stockholders' equity

$

1,152,901

$

1,035,728

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Net Service Revenue by Segment

(Amounts in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

For the Three Months
Ended September 30,

 

For the Nine Months
Ended September 30,

 

2024

 

2023

 

2024

 

2023

Net Service Revenues by Segment
 
Personal Care

$

215,433

$

201,882

$

636,253

$

590,227

Hospice

 

57,309

 

53,121

 

169,202

 

152,414

Home Health

 

17,045

 

15,718

 

52,000

 

39,659

Total Revenue

$

289,787

$

270,721

$

857,455

$

782,300

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Key Statistical and Financial Data (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

For the Three Months
Ended September 30,

 

For the Nine Months
Ended September 30,

 

 

2024

 

2023

 

2024

 

2023

 
 
Personal Care
 
States served at period end

 

-

 

 

-

 

 

21

 

 

21

 

Locations at period end

 

-

 

 

-

 

 

153

 

 

156

 

Average billable census total

 

37,701

 

 

38,590

 

 

37,803

 

 

38,668

 

Billable hours (in thousands)

 

7,776

 

 

7,690

 

 

23,098

 

 

22,964

 

Average billable hours per census per month

 

68.7

 

 

66.3

 

 

67.8

 

 

65.8

 

Billable hours per business day

 

117,822

 

 

118,314

 

 

117,849

 

 

117,765

 

Revenues per billable hour

$

27.66

 

$

26.18

 

$

27.49

 

$

25.58

 

Organic growth
- Revenue

 

6.8

%

 

13.9

%

 

8.4

%

 

12.5

 

 
Hospice
 
Locations served at period end

 

-

 

 

-

 

 

38

 

 

40

 

Admissions

 

3,105

 

 

3,176

 

 

9,771

 

 

9,576

 

Average daily census

 

3,534

 

 

3,453

 

 

3,457

 

 

3,426

 

Average discharge length of stay

 

96.3

 

 

97.5

 

 

92.8

 

 

93.2

 

Patient days

 

325,160

 

 

311,454

 

 

947,241

 

 

892,507

 

Revenue per patient day

$

176.25

 

$

175.19

 

$

179.43

 

$

175.23

 

Organic growth
- Revenue

 

3.5

%

 

3.1

%

 

5.2

%

 

1.5

 

- Average daily census

 

2.1

%

 

(0.9

)%

 

0.8

%

 

0.8

 

 
Home Health
 
Locations served at period end

 

-

 

 

-

 

 

23

 

 

24

 

New Admissions

 

4,437

 

 

4,265

 

 

14,257

 

 

11,597

 

Recertifications

 

3,353

 

 

2,672

 

 

9,798

 

 

5,816

 

Total Volume

 

7,790

 

 

6,937

 

 

24,055

 

 

17,413

 

Visits

 

104,730

 

 

94,637

 

 

322,713

 

 

240,758

 

Organic growth
- Revenue

 

(1.7

)%

 

(8.8

)%

 

(5.4

)%

 

(2.5

)

- New admissions

 

(5.7

)%

 

(18.9

)%

 

(0.3

)%

 

(13.5

)

- Volume

 

(3.7

)%

 

(14.3

)%

 

(0.4

)%

 

(9.3

)

 
Percentage of Revenues by Payor:
 
Personal Care
 
State, local and other governmental programs

 

54.2

%

 

50.4

%

 

53.0

%

 

50.4

 

Managed care organizations

 

43.3

 

 

46.4

 

 

44.3

 

 

46.2

 

Private duty

 

1.7

 

 

2.0

 

 

1.8

 

 

2.1

 

Commercial

 

0.7

 

 

0.8

 

 

0.7

 

 

0.8

 

Other

 

0.1

%

 

0.4

%

 

0.2

%

 

0.5

 

 
Hospice
 
Medicare

 

91.5

%

 

89.1

%

 

91.1

%

 

90.2

 

Commercial

 

5.0

 

 

6.8

 

 

5.2

 

 

5.8

 

Managed care organizations

 

3.2

 

 

3.4

 

 

3.3

 

 

3.3

 

Other

 

0.3

%

 

0.7

%

 

0.4

%

 

0.7

 

 
Home Health
 
Medicare

 

70.6

%

 

72.1

%

 

69.6

%

 

73.9

 

Managed care organizations

 

24.7

 

 

21.9

 

 

25.6

 

 

20.8

 

Commercial

 

4.5

 

 

4.2

 

 

4.2

 

 

4.3

 

Other

 

0.2

%

 

1.8

%

 

0.6

%

 

1.0

 

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Reconciliation of Non-GAAP Financial Measures

(Amounts in thousands, except per share data)

(Unaudited) (1)

 

 

 

 

 

 

 

 

 

For the Three Months
Ended September 30,

 

For the Nine Months
Ended September 30,

 

2024

 

2023

 

2024

 

2023

Reconciliation of Adjusted EBITDA to Net Income: (1)
 
Net income

$

20,163

 

$

15,411

 

$

54,072

 

$

42,938

 

 
Interest expense, net

 

(1,335

)

 

2,619

 

 

2,640

 

 

7,014

 

(Gain) Loss on sale of assets

 

(8

)

 

(1

)

 

(13

)

 

(5

)

Income tax expense

 

7,125

 

 

4,809

 

 

19,067

 

 

13,034

 

Depreciation and amortization

 

3,446

 

 

3,620

 

 

10,316

 

 

10,449

 

Impact of retroactive New York rate increase

 

-

 

 

-

 

 

-

 

 

(868

)

Acquisition expenses

 

2,072

 

 

1,763

 

 

7,647

 

 

4,792

 

Stock-based compensation expense

 

2,833

 

 

2,572

 

 

8,307

 

 

7,831

 

Restructure and other non-recurring costs

 

-

 

 

72

 

 

-

 

 

242

 

Adjusted EBITDA

$

34,296

 

$

30,865

 

$

102,036

 

$

85,427

 

 
 
Reconciliation of Adjusted Net Income to Net Income: (2)
 
Net income

$

20,163

 

$

15,411

 

$

54,072

 

$

42,938

 

 
(Gain) Loss on sale of assets

 

(8

)

 

(1

)

 

(13

)

 

(5

)

Impact of retroactive New York rate increase

 

-

 

 

-

 

 

-

 

 

(868

)

Acquisition expenses

 

2,072

 

 

1,763

 

 

7,647

 

 

4,792

 

Stock-based compensation expense

 

2,833

 

 

2,572

 

 

8,307

 

 

7,831

 

Restructure and other non-recurring costs

 

-

 

 

72

 

 

-

 

 

242

 

Tax Effect

 

(1,280

)

 

(1,048

)

 

(4,156

)

 

(2,793

)

 
Adjusted Net Income

$

23,780

 

$

18,769

 

$

65,857

 

$

52,137

 

 
 
Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)
 
Net income per diluted share

$

1.10

 

$

0.95

 

$

3.17

 

$

2.63

 

 
Impact of retroactive New York rate increase per diluted share

 

-

 

 

-

 

 

-

 

 

(0.04

)

Acquisition expenses per diluted share

 

0.08

 

 

0.08

 

 

0.33

 

 

0.23

 

Restructure and other non-recurring costs per diluted share

 

-

 

 

-

 

 

-

 

 

0.01

 

Stock-based compensation expense per diluted share

 

0.12

 

 

0.12

 

 

0.36

 

 

0.37

 

 
Adjusted net income per diluted share

$

1.30

 

$

1.15

 

$

3.86

 

$

3.20

 

 
Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)
 
Net service revenues

$

289,787

 

$

270,721

 

$

857,455

 

$

782,300

 

 
Revenues associated with the closure of certain sites

 

-

 

 

(259

)

 

-

 

 

(1,833

)

 
Adjusted net service revenues

$

289,787

 

$

270,462

 

$

857,455

 

$

780,467

 

 
 
Footnotes
 
(1) We define Adjusted EBITDA as earnings before net interest expense, income tax expense, depreciation and amortization, acquisition expenses, stock-based compensation expense, restructure expenses and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
(2) We define Adjusted Net Income as net income before acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
(3) We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition expenses, stock-based compensation expense and restructure and other non-recurring costs, gain on the sale of assets, and retroactive rate increases from New York. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.
(4) We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

 

Brian W. Poff

Executive Vice President, Chief Financial Officer

Addus HomeCare Corporation

(469) 535-8200

investorrelations@addus.com



Dru Anderson

FINN Partners

(615) 324-7346

dru.anderson@finnpartners.com

Source: Addus HomeCare Corporation

FAQ

What was Addus HomeCare's (ADUS) revenue growth in Q3 2024?

Addus HomeCare's net service revenues grew 7.0% to $289.8 million in Q3 2024 compared to $270.7 million in Q3 2023.

How much did Addus HomeCare (ADUS) earn per share in Q3 2024?

Addus HomeCare reported net income of $1.10 per diluted share and adjusted net income of $1.30 per diluted share in Q3 2024.

What percentage of Addus HomeCare's (ADUS) Q3 2024 revenue came from personal care services?

Personal care services accounted for 74.3% of Addus HomeCare's total revenue in Q3 2024.

When will Addus HomeCare (ADUS) complete the Gentiva acquisition?

Addus HomeCare expects to close the Gentiva acquisition in the fourth quarter of 2024.

Addus HomeCare Corp.

NASDAQ:ADUS

ADUS Rankings

ADUS Latest News

ADUS Stock Data

2.32B
18.10M
1.75%
101.42%
2.69%
Medical Care Facilities
Services-home Health Care Services
Link
United States of America
FRISCO